The Power List 2022 focuses on the top 10 VIPs in three key categories of medicine making
02/28/2023 | Stephanie Sutton
A video interview addressing the need for training in cell and gene therapy manufacturing.
02/25/2023 | Stephanie Sutton
A video interview covering collaboration in cell and gene therapy manufacturing
02/23/2023 | Rob Coker | 3 min read
What are the societal impacts of rapid advances in the life science sector?
02/21/2023 | Angus Stewart | 6 min read
Can digital tools help cell and gene therapy evolve?
02/16/2023 | Stephanie Sutton
Check out our video interview covering decentralized manufacturing and more.
02/13/2023 | James Wilson, Anshul Mangal | 5 min read
An early wave of investor enthusiasm followed by an economic crisis has landed our field in a sea of trouble – so how can we swim to shore?
01/09/2023 | Angus Stewart | 4 min read
What can cell and gene do to avoid a seemingly inevitable rush on supporting products and services?
12/30/2022 | Stuart Curbishley | 6 min read
Pharma depends on academia, but that relationship can become better… and more fluid
12/28/2022 | Naiara Tejados, PhD | 5 min read
Everything you ever wanted to know (but were too afraid to ask) about in vivo and ex vivo lentiviral vector therapies
12/27/2022 | Brian Mullan | 12 min read
Great successes are being seen in gene therapy, but there are still gaps in our scientific knowledge – and our manufacturing prowess.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
The Grand Winner
How Data Sharing Can Upgrade AI for Pharma
Welcome to the CRISPR Powerhouse